Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum

被引:91
作者
Liao, W
Yeung, SCJ
Chan, L
机构
[1] Baylor Coll Med, Dept Cell Biol, Div Endocrinol, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Med, Div Endocrinol, Houston, TX 77030 USA
关键词
D O I
10.1074/jbc.273.42.27225
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A major portion of newly synthesized apolipoprotein B (apoB) is degraded intracellularly, This degradation has been demonstrated to be mediated largely by the ubiquitin-proteasome pathway. We examined whether nascent apoB polypeptides or full-length apoB is selectively retrotranslocated from the endoplasmic reticulum into the cytosol for degradation. Herein, we found that full-length apoB as well as partial-length apoB peptides are ubiquitinated in HepG2 cells, and ubiquitination is an exclusively cytosolic process. Calnexin, which binds specifically to glycoproteins, has been postulated to promote apoB folding and complete translocation; me found that ubiquitinated apoB is bound to calnexin, suggesting that ubiquitinated apoB is glycosylated. In addition to calnexin binding, we have other pieces of evidence that the full-length intracellular ubiquitinated apoB is glycosylated, because (i) it binds to concanavalin A, and (ii) glycan can be demonstrated in the full-length ubiquitinated apoB by a chemical detection method involving oxidation of adjacent hydroxyl groups in the glycan moiety. Because glycosylation occurs inside the endoplasmic reticulum, the full-length glycosylated apoB must have been retrotranslocated into the cytosol for ubiquitination and proteasome-mediated degradation. Next we synchronized translation in HepG2 cells by puromycin treatment. A pulse-chase experiment using [S-35]methionine labeling of intracellular apoB in these synchronized cells demonstrated that nascent partial-length apoB peptides are also ubiquitinated cotranslationally, We conclude that the ubiquitin proteasome mediated degradation of apoB targets both nascent peptides cotranslationally before translocation as well as full-length apoB after its translocation into the endoplasmic reticulum.
引用
收藏
页码:27225 / 27230
页数:6
相关论文
共 24 条
[1]   The proteasome [J].
Baumeister, W ;
Lupas, A .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 1997, 7 (02) :273-278
[2]   Co-translational degradation of apolipoprotein B100 by the proteasome is prevented by microsomal triglyceride transfer protein - Synchronized translation studies on HepG2 cells treated with an inhibitor of microsomal triglyceride transfer protein [J].
Benoist, F ;
GrandPerret, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (33) :20435-20442
[3]   CALNEXIN - A MEMBRANE-BOUND CHAPERONE OF THE ENDOPLASMIC-RETICULUM [J].
BERGERON, JJM ;
BRENNER, MB ;
THOMAS, DY ;
WILLIAMS, DB .
TRENDS IN BIOCHEMICAL SCIENCES, 1994, 19 (03) :124-128
[4]   IN HEPG2 CELLS, TRANSLOCATION, NOT DEGRADATION, DETERMINES THE FATE OF THE DE-NOVO SYNTHESIZED APOLIPOPROTEIN-B [J].
BONNARDEL, JA ;
DAVIS, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (48) :28892-28896
[5]  
BORCHARDT RA, 1987, J BIOL CHEM, V262, P16394
[6]  
CHAN L, 1992, J BIOL CHEM, V267, P25621
[7]   PRIMARY SEQUENCE MAPPING OF HUMAN APOLIPOPROTEIN B-100 EPITOPES - COMPARISONS OF TRYPSIN ACCESSIBILITY AND IMMUNOREACTIVITY AND IMPLICATION FOR APOB CONFORMATION [J].
CHEN, PF ;
MARCEL, YL ;
YANG, CY ;
GOTTO, AM ;
MILNE, RW ;
SPARROW, JT ;
CHAN, L .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1988, 175 (01) :111-118
[8]   Calnexin and other factors that alter translocation affect the rapid binding of ubiquitin to ApoB in the Sec61 complex [J].
Chen, Y ;
Le Cahérec, F ;
Chuck, SL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (19) :11887-11894
[9]   The ubiquitin-proteasome pathway: The complexity and myriad functions of proteins death [J].
Ciechanover, A ;
Schwartz, AL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (06) :2727-2730
[10]  
COSGROVE PG, 1993, J LIPID RES, V34, P1983